Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Remdesivir
Critical severity 		Approved by FDA Experimental Antiviral Jan/18/2023
Mesenchymal stem cells
Critical severity 		Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
Bamlanivimab
Critical severity 		Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Convalescent plasma
Critical severity 		Emergency use authorization Experimental Antiviral May/16/2022
Anakinra 
Critical severity 		Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Dexamethasone
Critical severity 		Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
Tocilizumab
Critical severity 		Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
Critical severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Glucocorticoids
Critical severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Corticosteroids
Critical severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021
Favipiravir
Critical severity 		Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
IVIg
Critical severity 		Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Hydroxychloroquine sulfate
Critical severity 		Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
Arbidol
Critical severity 		Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021
Omega-3 polyunsaturated fatty acids
Critical severity 		Potential treatment - clinical evidence Natural product Unknown Mar/29/2021
Itolizumab
Critical severity 		Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/29/2021
Zofin
Critical severity 		Potential treatment - clinical evidence Experimental Other treatment Mar/17/2021
Famotidine
Critical severity 		Potential treatment - clinical evidence Used to treat other disease Unknown Mar/08/2021
Ascorbic acid
Critical severity 		Potential treatment - clinical evidence Natural product Other treatment Feb/26/2021
Heparin
Critical severity 		Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021
Export (.csv)